Taken together, our results provide a novel perspective on growth factor signaling by demonstrating the involvement of Orai1 in the pathogenesis of podocyte dysfunction and suggest new possible therapeutic strategies for proteinuric kidney diseases such as diabetic nephropathy. This evidence concerns the gene ORAI1 and diabetic kidney disease.